The rs738409 C>G polymorphism confers susceptibility to NAFLD by enabling the accumulation of PNPLA3 protein at the surface of hepatic lipid droplets, thereby inhibiting the activity of local lipases and impairing the mobilization of triglycerides from these droplets [23]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.